Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $7.59 | Prev. Close $7.88 | Circuit Range N/A |
Day Range $7.55 - $7.74 | Year Range $1.76 - $16.34 | Volume 1,138 |
Average Traded $7.62 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
10-Jun-26 | $7.59 | $7.74 | +0.00% |
10-Jun-26 | $7.59 | $7.74 | +2.65% |
08-Jun-26 | $7.54 | $7.54 | -0.98% |
05-Jun-26 | $7.75 | $7.62 | -2.31% |
04-Jun-26 | $8.04 | $7.79 | +2.70% |
03-Jun-26 | $7.66 | $7.59 | -3.62% |
02-Jun-26 | $8.06 | $7.88 | -4.72% |